Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phalanx Biotech Group is a leading Asian developer of DNA microarrays and genetic detection platforms. Its core offerings include the OneArray® line of whole genome expression arrays and custom arrays for gene expression profiling and miRNA analysis. The company also offers NGS services with bioinformatics support. Its CytoOneArray product enables advanced prenatal/postnatal chromosomal abnormality detection. It serves academic researchers as well as clinical labs worldwide. No clinical trial results apply since it is not a therapeutic developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phalanx Biotech Group.